Liaoning Cancer Hospital & Institute
Liaoning Cancer Hospital & Institute
Explore linked clinical trials.53 results · Page 1 of 3
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Robot-Assisted vs. Video-Assisted Lobectomy for NSCLC (RAVAR) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, non-small cell lung carcinoma, respiratory system disorder, respiratory tract neoplasm | Active, not recruiting | Not applicable | 2026-10-06 | NCT06524427 | |
| Epalrestat Combined With HAIC, Donafenib and Tislelizumab as First-line Treatment for Patients With Unresectable HCC and Diabetes | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nutritional and Metabolic Diseases, adenocarcinoma, carcinoma, diabetes mellitus, endocrine system disorder, epithelial neoplasm, glucose metabolism disease, hepatocellular carcinoma, liver disorder, metabolic disease, neoplasm | Not yet recruiting | Phase 2 | 2026-09-21 | NCT07557914 | |
| Apatinib With CDK4/6 Inhibitor and Endocrine Therapy in HR+/ HER2- Advanced Breast Cancer | Breast Cancer Metastatic | Active, not recruiting | Phase 2 | 2026-09-16 | NCT05759572 | |
| Safety of Mid and Low Rectal Cancer Surgery Without Dissection of the No.253 Lymph Node (S-M-O-O-T-H) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal cancer, rectal disorder, rectal neoplasm | Recruiting | Not applicable | 2026-09-15 | NCT06146946 | |
| Clinical Efficacy of Transarterial Infusion Chemotherapy for Unresectable Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Not applicable | 2026-09-11 | NCT07333053 | |
| ctDNA Analysis to Monitor the Risk of Progression After First-line Immunotherapy in Patients With Advanced NSCLC | Neoplasm, Residual, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, neoplasm | Active, not recruiting | Not stated | 2026-08-31 | NCT05198154 | |
| Optimal Application Timing of ADC Drugs for Advanced Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder | Recruiting | Phase 2 | 2026-06-18 | NCT07657130 | |
| Two-component Radiology-guided Autonomous Cascade Engine (TRACE) | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, Pathologic Processes, Pathological Conditions, Signs and Symptoms, digestive system disorder, digestive system neoplasm, disease, gastric neoplasm, neoplasm, stomach disorder | Recruiting | Not applicable | 2026-06-16 | NCT07651644 | |
| A Real-world Study of Immunotherapy Combination Regimens for Treating Liver Cancer in Cold Regions | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Site, liver cancer, liver disorder, neoplasm | Active, not recruiting | Not stated | 2026-06-12 | NCT07645209 | |
| The Effect of Perioperative Transcutaneous Electrical Acupoint Stimulation Combined With Traditional Chinese Medicine on Gastrointestinal Function Recovery in Patients Undergoing Abdominal Surgery | ERAS; Traditional Chinese Medication (TCM) | Recruiting | Not applicable | 2026-06-02 | NCT07081802 | |
| Conversion Therapy With FOLFOX-HAIC Plus Lenvatinib And Tislelizumab For Hepatocellular Carcinoma With Vp3 Portal Vein Tumor Thrombus | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, adenocarcinoma, carcinoma, epithelial neoplasm, hepatocellular carcinoma, liver disorder, neoplasm | Recruiting | Phase 2 | 2026-05-28 | NCT07483359 | |
| Proximal Gastrectomy vs Total Gastrectomy in Locally Advanced Upper Gastric Cancer After Neoadjuvant Therapy | Locally Advanced Gastric Cancer | Recruiting | Not applicable | 2026-04-27 | NCT06597227 | |
| Laparoscopic Staging for Stage III Gastric Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, digestive system disorder, digestive system neoplasm, gastric adenocarcinoma, gastric neoplasm, neoplasm, stomach disorder | Enrolling by invitation | Not applicable | 2026-04-16 | NCT07533825 | |
| Short-course Radiotherapy or Long-course Chemoradiation Followed by mFOLFOXIRI Consolidation Chemotherapy for Organ Preservation in Low Rectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder, rectal neoplasm | Active, not recruiting | Phase 2 | 2026-04-13 | NCT06417476 | |
| Intrathoracic Chemotherapy for TETs With Pleural Spread or Recurrence (CHOICE-2) | thymic epithelial neoplasm | Not yet recruiting | Not applicable | 2026-02-06 | NCT07383142 | |
| A Multi-modal Integrating Imaging and Cell-free DNA Methylation in Lung Cancer Early Detection (CMe-Lung): a Multi-center, Observational Study | Neoplasms by Site, Thoracic Neoplasms, lung cancer, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm | Not yet recruiting | Not stated | 2026-01-29 | NCT07375979 | |
| Postmastecomy Internal Mammary Nodal Irradiation for High-risk Breast Cancer Patients | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Active, not recruiting | Phase 3 | 2026-01-13 | NCT04320979 | |
| Clinical Study of SHR-A1811 With or Without Letrozole in Neoadjuvant Therapy for Early-Stage HR-Positive, HER2-Low Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast cancer, breast disorder, breast neoplasm, neoplasm, skin disorder | Not yet recruiting | Phase 2 | 2025-12-26 | NCT07305246 | |
| TREND-02 - a Phase II Exploratory De-escalation Trial of Neoadjuvant Sacituzumab Govitecan Plus Tislelizumab (SG/I) in Early Triple-negative Breast Cancer | Neoplasms by Site, Skin and Connective Tissue Diseases, breast disorder, breast neoplasm, neoplasm, skin disorder, triple-negative breast carcinoma | Not yet recruiting | Phase 2 | 2025-12-09 | NCT07271992 | |
| Immune Cell Therapy for Advanced Solid Tumors | Digestive System Diseases, Digestive System Neoplasms, Liver Neoplasms, Neoplasm Metastasis, Neoplasms by Site, Neoplastic Processes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Skin and Connective Tissue Diseases, Thoracic Neoplasms, breast disorder, breast neoplasm, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, liver disorder, lung disorder, lung neoplasm, neoplasm, rectal disorder, respiratory system disorder, respiratory tract neoplasm, skin disorder | Not yet recruiting | Phase 1 / Phase 2 | 2025-12-02 | NCT07260058 | |
| Adaptive Therapy for Resected Stage ⅠA2-Ⅱ NSCLC Patients With Undetectable MRD | non-small cell lung carcinoma | Recruiting | Not applicable | 2025-10-02 | NCT06924710 | |
| Comparing the Efficacy and Safety of Different Postoperative Adjuvant Regimens in Patients With Resectable Adenocarcinoma of the Esophagogastric Junction Who Underwent Radical Surgery After Neoadjuvant Chemotherapy Combined With Immunotherapy and Achieved pCR in Postoperative Pathology | Gastric / Gastroesophageal Junction Adenocarcinoma | Not yet recruiting | Phase 4 | 2025-09-08 | NCT07161453 | |
| RT for Adenocarcinoma/Adenosquamous Carcinoma | cervical adenocarcinoma, cervical adenosquamous carcinoma | Active, not recruiting | Phase 1 / Phase 2 | 2025-09-04 | NCT07153952 | |
| Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as Postoperative Adjuvant Regimens in Patients With Resectable Gastric Cancer/Adenocarcinoma of the Esophagogastric Junction After Radical Surgery | Gastric / Gastroesophageal Junction Adenocarcinoma | Not yet recruiting | Phase 4 | 2025-08-29 | NCT07149181 | |
| Comparing the Efficacy and Safety of Chemotherapy Combined With or Without Immunotherapy as an Adjuvant Treatment After Radical Surgery for Patients With Resectable Adenocarcinoma of the Esophagogastric Junction of Gastric Cancer | Gastric / Gastroesophageal Junction Adenocarcinoma | Not yet recruiting | Phase 4 | 2025-08-20 | NCT07132528 |